Format

Send to

Choose Destination
Eur Urol. 2010 Sep;58(3):464-5.

Words of wisdom. Re: Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Scher HI, Beer TM, Higano CS, et al. Prostate Cancer Foundation/Department of Defense Prostate Cancer Clinical Trials Consortium.

Author information

1
Department of Urology, Charité Berlin, Hindenburgdamm 30, 12200 Berlin, Germany. miller@medizin.fu-berlin.de
PMID:
20845529

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center